More pediatric HIV patients on antiretroviral therapy

More pediatric HIV patients on antiretroviral therapy
The proportion of perinatally HIV-infected youth on antiretroviral therapy has increased, leading to decreases in rates of viremia and advanced immunosuppression in recent years, according to a study published in the September issue of the Journal of the Pediatric Infectious Diseases Society.

(HealthDay)—The proportion of perinatally HIV (PHIV)-infected youth on antiretroviral therapy (ART) has increased, leading to decreases in rates of viremia and advanced immunosuppression in recent years, according to a study published in the September issue of the Journal of the Pediatric Infectious Diseases Society.

Allison L. Agwu, M.D., from Johns Hopkins University in Baltimore, and colleagues retrospectively studied 521 PHIV-infected youth, 12 years and older, followed at 16 HIV clinics participating in the HIV Research Network between 2002 and 2010.

The researchers found that, from 2002 and 2010, the of PHIV-infected youth in care increased from 14 to 18 years. The proportion of patients prescribed ART increased from 67.4 to 84 percent, with virologic suppression concurrently increasing from 35.5 to 63.0 percent (P trend < 0.01). Factors independently associated with CD4 <200 cells/mm³ included older age, black and Hispanic race/ethnicity, and increasing viremia. A higher likelihood of detectable viremia was independently associated with older age, black race and Hispanic ethnicity, while more recent year of evaluation and being prescribed ART were associated with a lower likelihood of viremia.

"Factors associated with advanced and viremia offer the chance to define strategies to optimize outcomes," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Onset of puberty is delayed in HIV-infected children

date Aug 19, 2013

(HealthDay)—Onset of puberty is significantly delayed in perinatally HIV-infected (PHIV) children compared with those who are HIV-exposed but uninfected (HEU), but combination antiretroviral therapy may ...

HIV treatment use increases in the US

date Sep 03, 2012

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious ...

Recommended for you

CDC examines prevalence of undiagnosed HIV

date 16 hours ago

(HealthDay)—Many people have undiagnosed HIV, with the prevalence varying by geographic area, according to a report published in the June 26 issue of the U.S. Centers for Disease Control and Prevention's ...

Potential new HIV therapy seen in immune cells

date Jun 29, 2015

A research team led by Weill Cornell Medical College scientists has discovered a way to limit replication of the most common form of HIV at a key moment when the infection is just starting to develop. The ...

More secondary schooling reduces HIV risk

date Jun 29, 2015

Longer secondary schooling substantially reduces the risk of HIV infection—especially for girls—and could be a very cost-effective way to halt the spread of the virus, according to researchers from Harvard ...

Bill Gates hopeful of AIDS vaccine in 10 years

date Jun 26, 2015

Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.